Clinical trial
Application of Oxford Nanopore Adaptive Sequencing Method in Infection Post Liver Transplantation
NCT06542042 is registered in ClinicalTrials.gov with Shenzhen Third People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Oxford Nanopore Adaptive Sequencing Method in Infection Post Liver Transplantation
- Lead sponsor
- Shenzhen Third People's Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 1, 2024
- Completion date
- October 30, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver transplant infection